Table 1:

Demographic and neuropathologic data of subjects

Case No.NoaSexAge (yr)PMD (h:min)bDD (yr)MS TypeCOD
MS
    1M806:0545SPMSPneumonia
    2F813:3027PPMSPneumonia
    3M7510:1050NAPneumonia
    4F667:3017NAPulmonary hypertension
    5M714:0015SPMSPulmonary carcinoma
    6F546:0016SPMSLiver cancer
    7M634:3025SPMSPneumonia
    8M783:0033SPMSEuthanasia
    9M595:0021SPMSEuthanasia
    10M5610:1013NASuicide
    11F568:2532SPMSPneumonia
    12F543:3031SPMSHeart failure
    13M584:0027SPMSPneumonia
    14F956:3055SPMSUnknown
    15F816:3021SPMSHeart failure
    Mean68.5 ± 12.75:56 ± 2:2728.5 ± 12.9
Control
    204F72>24:00Myocardial infarct
    213F58<24:00Breast cancer
    223F76<24:00Pneumonia
    232F76<8:00Pneumonia
    Mean70.5 ± 8.5
  • Note:—PMD indicates postmortem delay; DD, disease duration since diagnosis; SPMS, secondary-progressive MS; PPMS, primary-progressive MS; COD, cause of death; NA, unavailable/unknown; –, not applicable.

  • a The numbers indicate number of hemispheric sections included per case.

  • b Control cases are not part of the rapid postmortem examination program and therefore have a longer PMD.